FDA Rejects Female-Viagra Aphrodisiac Intrinsa, But Europe Quickly Approves It
5 01 2008
The Intrinsa patch, developed by Proctor & Gamble, was rejected by the US Food & Drug Administration, but quickly approved in Europe.
What are Intrinsa Patches?
Intrinsa is a prescription drug manufactured by the pharmaceutical company Proctor & Gamble. Intrinsa is approved for the treatment of hypoactive sexual desire disorder (HSDD). HSDD refers to the deficiency or absence or sexual thoughts and desires in women, however it is not considered a disorder until it causes a patient considerable distress or relationship problems. Intrinsa is supplied in a patch form that contains the active substance testosterone, which is produced naturally in the ovaries in menopausal women. After menopause, testosterone levels drop dramatically resulting in a decreased sex drive. Intrinsa helps increase testosterone levels again, hence restoring womens libido. - atlanticdrugs.com
The female aphrodisiac will initially only be available on prescription for post-menopausal women with diagnosed sexual problems. However it is likely that the patches will later become “lifestyle” drugs bought freely over the counter - used by younger women with no sexual problems who simply want to increase their libido, (read, wanna get laid more often).
Manufacturers Procter and Gamble say the patch helped boost the flagging libido in hundreds of women in tests, and increased the amount of sexual activity they enjoyed. Dramatically successful results were found in menopausal women who had been diagnosed with hypoactive sexual desire disorder, in which libido and sexual activity is reduced - leading to psychological distress. More than 500 took part in the drug company’s six-month study, with half unaware they had been given a dummy patch. - dailymail.co.uk
Procter & Gamble Pharmaceuticals’ United Kingdom website for Intrinsa: http://desireandmenopause.co.uk/
Interesting to me is that the only active ingredient in the Intrinsa patch is a dose of the male hormone testosterone.
go figure.

[…] mind that the previous testosterone delivering product developed by Biosante Pharmaceuticals, the Intrinsa Patch, was rejected by the US FDA. (Approved by the EU though and available […]